ClinicalTrials.govpublic full text
A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia
diphtheria, tetanus, pertussis, hepatitis b, haemophilus influenzae type b
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 136424
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.